Search

Your search keyword '"Alanio, A."' showing total 177 results

Search Constraints

Start Over You searched for: Author "Alanio, A." Remove constraint Author: "Alanio, A." Database MEDLINE Remove constraint Database: MEDLINE
177 results on '"Alanio, A."'

Search Results

1. Interlaboratory assays from the fungal PCR Initiative and the Modimucor Study Group to improve qPCR detection of Mucorales DNA in serum: one more step toward standardization.

2. A new quantitative reverse transcription PCR assay to improve the routine diagnosis of paracoccidioidomycosis.

Catalog

Books, media, physical & digital resources

3. Cryptococcus neoformans/gattii and Histoplasma capsulatum var. capsulatum infections on tissue sections: Diagnostic pitfalls and relevance of an integrated histomolecular diagnosis.

4. Immunometabolic reprogramming in macrophages infected with active and dormant Cryptococcus neoformans : differential modulation of respiration, glycolysis, and fatty acid utilization.

5. Combined antifungal therapy with immunostimulation for refractory cutaneous and peritoneal mucormycosis caused by Rhizopus microsporus.

6. Implementation and validation of a new qPCR assay to detect imported human Plasmodium species.

7. Dynamics of Histoplasma fungal load in people living with HIV with disseminated histoplasmosis under treatment with liposomal amphotericin B.

8. Laboratory practices for the diagnosis and management of mucormycosis in France, 2024.

9. Reverse-transcriptase real-time PCR in the diagnostic strategy for invasive infections caused by Aspergillus fumigatus .

10. Reappraising Cladophialophora bantiana phaeohyphomycosis in France: retrospective nation-based study.

11. Auranofin is active against Histoplasma capsulatum and reduces the expression of virulence-related genes.

12. Evaluation of an in-house pan-Malassezia quantitative PCR in human clinical samples.

13. Strengths and limitations of molecular diagnostics for Pneumocystis jirovecii pneumonia.

14. Evolutionary origin and population diversity of a cryptic hybrid pathogen.

15. Risk Factors and Outcome Associated With Fungal Infections in Patients With Severe Burn Injury: 10-year Retrospective IFI-BURN Study.

16. Current knowledge and practice of Candida auris screening in France: A nationwide survey from the French Society of Medical Mycology (SFMM).

17. Epidemiology and prognostic factors of mucormycosis in France (2012-2022): a cross-sectional study nested in a prospective surveillance programme.

18. Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM.

19. Epidemiology, Clinical Manifestations, Treatment, and Outcome of Mucormycosis: A Review of 77 Cases From a Single Center in France.

20. Polymerase Chain Reaction on Respiratory Tract Specimens of Immunocompromised Patients to Diagnose Pneumocystis Pneumonia: A Systematic Review and Meta-analysis.

22. Dual quantitative PCR assays for the rapid detection of Trichophyton indotineae from clinical samples.

23. Features of cryptococcosis among 652 HIV-seronegative individuals in France: a cross-sectional observational study (2005-2020).

24. Revealing the hidden interplay: The unexplored relationship between fungi and viruses beyond HIV, SARS-CoV-2, and influenza.

25. Development and validation of quantitative PCR assays for HIV-associated cryptococcal meningitis in sub-Saharan Africa: a diagnostic accuracy study.

26. Induction of Dormancy in Cryptococcus neoformans In Vitro: The HypNOS Protocol.

27. Assessing Phagocytosis of Cryptococcus neoformans Cells in Human Monocytes or the J774 Murine Macrophage Cell Line.

28. In Vitro Titan Cell Generation in Cryptococcus neoformans and Automated Cell Size Measurements.

29. Cryptococcus neoformans Infections Differ Among Human Immunodeficiency Virus (HIV)-Seropositive and HIV-Seronegative Individuals: Results From a Nationwide Surveillance Program in France.

30. Bronchial aspirate obtained during bronchoscopy yields increased fungal load compared to bronchoalveolar lavage fluid in patients at risk of invasive aspergillosis and Pneumocystis pneumonia.

31. Kicking sleepers out of bed: Macrophages promote reactivation of dormant Cryptococcus neoformans by extracellular vesicle release and non-lytic exocytosis.

32. Re: 'Which trial do we need? Combination treatment of Pneumocystis jirovecii pneumonia in non-HIV infected patients' by Cornely et al.

33. Allergic fungal rhinosinusitis and eosinophilic mucin chronic rhinosinusitis: Differential diagnostic criteria. A two-center comparative study following STROBE methodology.

34. Cryptococcal meningitis and cerebral vasculitis in a patient with primary intestinal lymphangiectasia: a case report.

35. A multicentre external quality assessment: A first step to standardise PCR protocols for the diagnosis of histoplasmosis and coccidioidomycosis.

36. Coregulation of extracellular vesicle production and fluconazole susceptibility in Cryptococcus neoformans .

37. Invasive fungal diseases in patients with autoimmune diseases: a case series from the French RESSIF network.

38. Performance of the beta-glucan test for the diagnosis of invasive fusariosis and scedosporiosis: a meta-analysis.

39. Development and validation of a new quantitative reverse transcription PCR assay for the diagnosis of human sporotrichosis.

40. Gradient concentration strip-specific epidemiological cut-off values of antifungal drugs in various yeast species and five prevalent Aspergillus species complexes.

41. Multicenter Evaluation of the FilmArray Blood Culture Identification 2 Panel for Pathogen Detection in Bloodstream Infections.

42. The role of glycosylphosphatidylinositol (gpi) anchored proteins in Cryptococcusneoformans.

43. Engineered Fluorescent Strains of Cryptococcus neoformans: a Versatile Toolbox for Studies of Host-Pathogen Interactions and Fungal Biology, Including the Viable but Nonculturable State.

44. First Patient-to-Patient Intrahospital Transmission of Clade I Candida auris in France Revealed after a Two-Month Incubation Period.

45. Investigation of CryptoPS LFA-positive sera in patients at risk of cryptococcosis.

46. Evaluation of Serum Mucorales Polymerase Chain Reaction (PCR) for the Diagnosis of Mucormycoses: The MODIMUCOR Prospective Trial.

47. Detection of circulating DNA for the diagnosis of invasive fusariosis: retrospective analysis of 15 proven cases.

48. Multiple colony antifungal susceptibility testing detects polyresistance in clinical Candida cultures: a European Confederation of Medical Mycology excellence centers study.

49. Analytical Performance of the Commercial MucorGenius ® Assay as Compared to an In-House qPCR Assay to Detect Mucorales DNA in Serum Specimens.

50. Cryptococcal Meningitis in Kidney Transplant Recipients: A Two-Decade Cohort Study in France.